Givaudan SA (GIVN) - Net Assets
Based on the latest financial reports, Givaudan SA (GIVN) has net assets worth CHF4.57 Billion CHF (≈ $5.78 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF11.86 Billion ≈ $15.00 Billion USD) and total liabilities (CHF7.30 Billion ≈ $9.22 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Givaudan SA assets under control for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF4.57 Billion |
| % of Total Assets | 38.5% |
| Annual Growth Rate | 2.21% |
| 5-Year Change | 15.91% |
| 10-Year Change | 38.72% |
| Growth Volatility | 13.07 |
Givaudan SA - Net Assets Trend (2002–2025)
This chart illustrates how Givaudan SA's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see Givaudan SA market capitalisation.
Annual Net Assets for Givaudan SA (2002–2025)
The table below shows the annual net assets of Givaudan SA from 2002 to 2025. Explore GIVN cash flow metrics to assess how effectively this company generates cash.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CHF4.57 Billion ≈ $5.78 Billion |
-0.22% |
| 2024-12-31 | CHF4.58 Billion ≈ $5.79 Billion |
+14.51% |
| 2023-12-31 | CHF4.00 Billion ≈ $5.05 Billion |
-5.64% |
| 2022-12-31 | CHF4.24 Billion ≈ $5.36 Billion |
+7.51% |
| 2021-12-31 | CHF3.94 Billion ≈ $4.98 Billion |
+12.34% |
| 2020-12-31 | CHF3.51 Billion ≈ $4.44 Billion |
-4.13% |
| 2019-12-31 | CHF3.66 Billion ≈ $4.63 Billion |
-1.96% |
| 2018-12-31 | CHF3.73 Billion ≈ $4.72 Billion |
+5.48% |
| 2017-12-31 | CHF3.54 Billion ≈ $4.47 Billion |
+7.44% |
| 2016-12-31 | CHF3.29 Billion ≈ $4.16 Billion |
-3.57% |
| 2015-12-31 | CHF3.42 Billion ≈ $4.32 Billion |
+0.06% |
| 2014-12-31 | CHF3.41 Billion ≈ $4.31 Billion |
-0.29% |
| 2013-12-31 | CHF3.42 Billion ≈ $4.33 Billion |
-6.98% |
| 2012-12-31 | CHF3.68 Billion ≈ $4.65 Billion |
+5.29% |
| 2011-12-31 | CHF3.50 Billion ≈ $4.42 Billion |
+1.42% |
| 2010-12-31 | CHF3.45 Billion ≈ $4.36 Billion |
+22.55% |
| 2009-12-31 | CHF2.81 Billion ≈ $3.56 Billion |
+34.35% |
| 2008-12-31 | CHF2.09 Billion ≈ $2.65 Billion |
-21.99% |
| 2007-12-31 | CHF2.68 Billion ≈ $3.39 Billion |
-4.04% |
| 2006-12-31 | CHF2.80 Billion ≈ $3.53 Billion |
+14.73% |
| 2005-12-31 | CHF2.44 Billion ≈ $3.08 Billion |
+22.59% |
| 2004-12-31 | CHF1.99 Billion ≈ $2.51 Billion |
-23.12% |
| 2003-12-31 | CHF2.59 Billion ≈ $3.27 Billion |
-6.51% |
| 2002-12-31 | CHF2.77 Billion ≈ $3.50 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Givaudan SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 126.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF7.41 Billion | 163.39% |
| Common Stock | CHF92.00 Million | 2.03% |
| Other Comprehensive Income | CHF-2.93 Billion | -64.60% |
| Total Equity | CHF4.54 Billion | 100.00% |
Givaudan SA Competitors by Market Cap
The table below lists competitors of Givaudan SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Viking Holdings Ltd
NYSE:VIK
|
$25.74 Billion |
|
Novonesis (Novozymes) A/S
CO:NSIS-B
|
$25.75 Billion |
|
Cheniere Energy Partners LP
NYSE MKT:CQP
|
$25.77 Billion |
|
Ares Management LP
NYSE:ARES
|
$25.81 Billion |
|
BeiGene Ltd.
F:49B
|
$25.73 Billion |
|
Hyundai Mobis Co.,Ltd
KO:012330
|
$25.72 Billion |
|
Mettler-Toledo International Inc
NYSE:MTD
|
$25.66 Billion |
|
Zhejiang Sanhua Co Ltd
SHE:002050
|
$25.62 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Givaudan SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,578,000,000 to 4,537,000,000, a change of -41,000,000 (-0.9%).
- Net income of 1,071,000,000 contributed positively to equity growth.
- Dividend payments of 645,000,000 reduced retained earnings.
- Share repurchases of 27,000,000 reduced equity.
- Other comprehensive income decreased equity by 483,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF1.07 Billion | +23.61% |
| Dividends Paid | CHF645.00 Million | -14.22% |
| Share Repurchases | CHF27.00 Million | -0.6% |
| Other Comprehensive Income | CHF-483.00 Million | -10.65% |
| Other Changes | CHF43.00 Million | +0.95% |
| Total Change | CHF- | -0.90% |
Book Value vs Market Value Analysis
This analysis compares Givaudan SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.69x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 8.62x to 5.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | CHF323.20 | CHF2785.00 | x |
| 2003-12-31 | CHF320.66 | CHF2785.00 | x |
| 2004-12-31 | CHF261.27 | CHF2785.00 | x |
| 2005-12-31 | CHF336.86 | CHF2785.00 | x |
| 2006-12-31 | CHF394.71 | CHF2785.00 | x |
| 2007-12-31 | CHF375.83 | CHF2785.00 | x |
| 2008-12-31 | CHF279.58 | CHF2785.00 | x |
| 2009-12-31 | CHF352.01 | CHF2785.00 | x |
| 2010-12-31 | CHF381.43 | CHF2785.00 | x |
| 2011-12-31 | CHF382.13 | CHF2785.00 | x |
| 2012-12-31 | CHF401.54 | CHF2785.00 | x |
| 2013-12-31 | CHF369.07 | CHF2785.00 | x |
| 2014-12-31 | CHF365.86 | CHF2785.00 | x |
| 2015-12-31 | CHF366.43 | CHF2785.00 | x |
| 2016-12-31 | CHF354.57 | CHF2785.00 | x |
| 2017-12-31 | CHF381.01 | CHF2785.00 | x |
| 2018-12-31 | CHF399.29 | CHF2785.00 | x |
| 2019-12-31 | CHF391.95 | CHF2785.00 | x |
| 2020-12-31 | CHF375.60 | CHF2785.00 | x |
| 2021-12-31 | CHF422.89 | CHF2785.00 | x |
| 2022-12-31 | CHF457.36 | CHF2785.00 | x |
| 2023-12-31 | CHF431.38 | CHF2785.00 | x |
| 2024-12-31 | CHF494.03 | CHF2785.00 | x |
| 2025-12-31 | CHF489.35 | CHF2785.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Givaudan SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.61%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.33%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 2.61x
- Recent ROE (23.61%) is above the historical average (15.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 9.36% | 9.65% | 0.59x | 1.65x | CHF-17.60 Million |
| 2003 | 8.44% | 8.03% | 0.60x | 1.76x | CHF-40.40 Million |
| 2004 | 16.96% | 12.57% | 0.62x | 2.18x | CHF138.30 Million |
| 2005 | 16.67% | 14.61% | 0.62x | 1.85x | CHF162.50 Million |
| 2006 | 14.75% | 14.16% | 0.62x | 1.68x | CHF132.70 Million |
| 2007 | 3.51% | 2.27% | 0.52x | 2.95x | CHF-173.60 Million |
| 2008 | 5.32% | 2.72% | 0.58x | 3.35x | CHF-97.70 Million |
| 2009 | 7.09% | 5.03% | 0.56x | 2.53x | CHF-81.50 Million |
| 2010 | 9.87% | 8.02% | 0.61x | 2.01x | CHF-4.60 Million |
| 2011 | 7.21% | 6.44% | 0.58x | 1.92x | CHF-97.50 Million |
| 2012 | 11.17% | 9.65% | 0.67x | 1.73x | CHF43.00 Million |
| 2013 | 14.31% | 11.22% | 0.70x | 1.81x | CHF147.70 Million |
| 2014 | 16.50% | 12.78% | 0.68x | 1.90x | CHF221.70 Million |
| 2015 | 18.59% | 14.44% | 0.70x | 1.84x | CHF293.50 Million |
| 2016 | 19.56% | 13.81% | 0.72x | 1.98x | CHF314.70 Million |
| 2017 | 20.35% | 14.25% | 0.69x | 2.07x | CHF366.20 Million |
| 2018 | 17.87% | 12.00% | 0.60x | 2.50x | CHF292.00 Million |
| 2019 | 19.29% | 11.32% | 0.60x | 2.86x | CHF338.00 Million |
| 2020 | 21.29% | 11.75% | 0.59x | 3.05x | CHF394.00 Million |
| 2021 | 20.90% | 12.28% | 0.58x | 2.91x | CHF428.10 Million |
| 2022 | 20.23% | 12.03% | 0.62x | 2.72x | CHF432.80 Million |
| 2023 | 22.36% | 12.91% | 0.62x | 2.79x | CHF493.70 Million |
| 2024 | 23.81% | 14.71% | 0.61x | 2.64x | CHF632.20 Million |
| 2025 | 23.61% | 14.33% | 0.63x | 2.61x | CHF617.30 Million |
Industry Comparison
This section compares Givaudan SA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,511,662,000
- Average return on equity (ROE) among peers: 17.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Givaudan SA (GIVN) | CHF4.57 Billion | 9.36% | 1.60x | $25.74 Billion |
| Clariant AG (CLN) | $2.38 Billion | 4.87% | 1.91x | $2.41 Billion |
| EMS-CHEMIE HOLDING AG (EMSN) | $1.11 Billion | 20.90% | 0.50x | $14.92 Billion |
| Gurit Holding AG (GURN) | $171.98 Million | 27.28% | 1.19x | $119.06 Million |
| Sika AG (SIKA) | $2.38 Billion | 18.42% | 1.02x | $25.37 Billion |
About Givaudan SA
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & … Read more